Allergan Management Discusses Q2 2012 Results - Earnings Call Transcript

Allergan (AGN)

Q2 2012 Earnings Call

August 01, 2012 11:00 am ET

Executives

James M. Hindman - Chief Financial Officer

David E. I. Pyott - Chairman, Chief Executive officer and President

Jeffrey L. Edwards - Chief Financial Officer and Executive Vice President of Finance & Business Development

Scott M. Whitcup - Chief Scientific Officer and Executive Vice President of Research & Development

Joann Bradley

Analysts

Shibani Malhotra - RBC Capital Markets, LLC, Research Division

Catherine J. Arnold - Crédit Suisse AG, Research Division

David Risinger - Morgan Stanley, Research Division

Gregory B. Gilbert - BofA Merrill Lynch, Research Division

Aaron Gal - Sanford C. Bernstein & Co., LLC., Research Division

Frank H. Pinkerton - SunTrust Robinson Humphrey, Inc., Research Division

Rebecca M. Forest - Piper Jaffray Companies, Research Division

Ken Cacciatore - Cowen and Company, LLC, Research Division

Seamus Fernandez - Leerink Swann LLC, Research Division

Annabel Samimy - Stifel, Nicolaus & Co., Inc., Research Division

Marc Goodman - UBS Investment Bank, Research Division

David G. Buck - The Buckingham Research Group Incorporated

Steve Willoughby - Cleveland Research Company

Douglas D. Tsao - Barclays Capital, Research Division

Lawrence Biegelsen - Wells Fargo Securities, LLC, Research Division

Gary Nachman - Susquehanna Financial Group, LLLP, Research Division

Gregory Waterman - Goldman Sachs Group Inc., Research Division

Presentation

Operator

Hello, and welcome to the Allergan Second Quarter 2012 Earnings Call. [Operator Instructions] At the request of the company, today's conference is being recorded. If anyone has any objections, you may disconnect at this time.

I would like to introduce today's conference host, Mr. Jim Hindman, Senior Vice President, Treasury, Risk and Investor Relations. Sir, you may begin.

If you liked this article you might like

Elizabeth Warren Slams Wells Fargo, Equifax: Cramer's Top Takeaways

Centene: Cramer's Top Takeaways

The Pitney Bowes Transformation: Cramer's Top Takeaways

Healthcare Trust of America, Marathon Petroleum: 'Mad Money' Lightning Round

How Long Can This Rally Run?: Cramer's 'Mad Money' Recap (Monday 9/19/17)